老年人呼吸困难、衰弱与肌少症
基于社区老年人群的前瞻性队列研究(n=780),采用改良医学研究委员会呼吸困难量表(≥2分)和COPD评估测试(≥10分)定义呼吸困难,分别用衰弱指数、衰弱表型和FRAIL问卷定义衰弱,用2019年亚洲肌少症工作组标准定义肌少症。结果显示呼吸困难组衰弱患病率显著高于无呼吸困难组(衰弱指数42.6% vs 10.5%,衰弱表型26.1% vs 8.9%,FRAIL问卷23.0% vs 4.2%),肌少症患病率38.3% vs 26.9%,均P<.01。多因素logistic回归显示衰弱指数(aOR 9.29)、FRAIL问卷(aOR 5.21)、衰弱表型(aOR 3.09)及肌少症表型评分2分(aOR 2.00)和3分(aOR 2.04)与呼吸困难相关。呼吸困难组无机构化生存累积发生率更高(P=.02)。作者认为测量衰弱和肌少症可能为预防年龄相关呼吸困难提供机会。
要点
- 社区老年人中,呼吸困难组衰弱患病率显著高于无呼吸困难组:衰弱指数42.6% vs 10.5%,衰弱表型26.1% vs 8.9%,FRAIL问卷23.0% vs 4.2%(P<.01)。
- 呼吸困难组肌少症患病率38.3%,无呼吸困难组26.9%(P<.01)。
- 多因素logistic回归显示衰弱指数(aOR 9.29)、FRAIL问卷(aOR 5.21)、衰弱表型(aOR 3.09)与呼吸困难相关。
- 肌少症表型评分2分(aOR 2.00)和3分(aOR 2.04)与呼吸困难相关(参照0分)。
- 呼吸困难组无机构化生存累积发生率更高(P=.02)。
适用人群与场景
- 社区居住的老年人(n=780),来自基于人群的前瞻性队列研究。
诊断标准与关键阈值
- 呼吸困难定义:改良医学研究委员会呼吸困难量表≥2分或COPD评估测试≥10分。
- 衰弱定义:衰弱指数、衰弱表型或FRAIL问卷(疲劳、阻力、行走、疾病、体重减轻)。
- 肌少症定义:2019年亚洲肌少症工作组标准;肌少症表型评分量化符合标准数量。
研究设计与关键结果
- 研究类型:基于人群的前瞻性队列研究,样本量780例社区老年人。
- 主要结果:呼吸困难组 vs 无呼吸困难组衰弱患病率:衰弱指数42.6% vs 10.5%,衰弱表型26.1% vs 8.9%,FRAIL问卷23.0% vs 4.2%;肌少症38.3% vs 26.9%,均P<.01。
- 多因素logistic回归(校正年龄、性别、慢性气道疾病、吸烟状态、BMI、肺功能、社会经济状态、共病、其他老年因素):衰弱指数aOR 9.29,FRAIL问卷aOR 5.21,衰弱表型aOR 3.09;肌少症表型评分2分aOR 2.00、3分aOR 2.04(参照0分)。
- 无机构化生存累积发生率在呼吸困难组更高(P=.02)。
证据类型、等级与局限
- 证据类型:基于人群的前瞻性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,在社区老年人中测量肌少症和衰弱可能为预防年龄相关呼吸困难提供机会。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Breathlessness shares aging mechanisms with frailty and sarcopenia.
RESEARCH QUESTION: Are frailty and sarcopenia associated with breathlessness itself?
STUDY DESIGN AND METHODS: We analyzed data from a population-based, prospective cohort study of 780 community-dwelling older adults. Breathlessness was defined using the modified Medical Research Council dyspnea scale (≥ 2 points) and the COPD Assessment Test (≥ 10 points). Frailty was defined by frailty index (FI); frailty phenotype; and fatigue, resistance, ambulation, illness, and weight loss (FRAIL) questionnaire results. Sarcopenia was defined by the Asian Working Group for Sarcopenia in 2019. Sarcopenia phenotype score quantified the number of criteria met. The associations of frailty and sarcopenia with breathlessness were evaluated by logistic regression analyses. Adjusted ORs (aORs) were calculated, accounting for age, sex, chronic airway disease, smoking status, BMI, lung functions, socioeconomic status (living alone, income, education), comorbid conditions (hypertension, diabetes, malignancy, myocardial infarction, heart failure), and other geriatric contributors (cognitive dysfunction, depression, malnutrition, polypharmacy, fall history in the past year). Institutionalization-free survival was compared by log-rank test.
RESULTS: The prevalence of frailty was higher in the breathlessness group compared with the group without breathlessness (42.6% vs 10.5% by FI, 26.1% vs 8.9% by frailty phenotype, and 23.0% vs 4.2% by FRAIL questionnaire) and sarcopenia (38.3% vs 26.9%), with P < .01 for all comparisons. The multivariable logistic regression analyses showed that frailty (FI [aOR, 9.29], FRAIL questionnaire [aOR, 5.21], and frailty phenotype [aOR, 3.09]) and sarcopenia phenotype score (2 [aOR, 2.00] and 3 [aOR, 2.04] compared with 0) were associated with breathlessness. The cumulative incidence of institutionalization-free survival was higher in the breathlessness group than its counterparts (P = .02).
INTERPRETATION: These findings suggest that frailty and sarcopenia strongly contribute to breathlessness in community-dwelling older adults. Measuring sarcopenia and frailty in older adults may offer opportunities to prevent age-related breathlessness.
参考来源
- An TJ, Lim J, Lee H, et al. Breathlessness, Frailty, and Sarcopenia in Older Adults. Chest. 2024. PMID: 39209061. doi:10.1016/j.chest.2024.07.180
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。